Immunotherapy has delivered one of the most promising advances for cancer research. Yet a better understanding of the interactions of cancer cells with the immune system –summarized by the cancer-immunity cycle—is needed to fulfill this therapeutic promise for most patients.

This symposium will bring together cancer immunology research in both the basic, translational, and clinical space, highlighting important areas of recent progress as well as areas that remain challenges to the field.

Topics:

• Activation of the cycle: innate signaling and antigen presentation
• Implementation of the cycle: T cell differentiation, exhaustion and activation
• Tumor microenvironment
• Manipulating the cycle: synthetic immunity
• Is immunotherapy successful cancer therapy?